Your search for esrd returned 70 results

Active Filters

Click on a filter below to refine your search. Remove a filter to broaden your search.

Your search for esrd returned 70 results

Sort Results:

Relevant Recent
News

Fenofibrate Found Safe in Diabetes With Renal Impairment

Long-term daily use of fenofibrate is beneficial for patients with type 2 diabetes and moderate renal impairment and is not associated with an increase in drug-related safety concerns compared with those with mild renal impairment.
News

Onglyza labeling updated to include new clinical trial data

The labeling for Onglyza (saxagliptin; Bristol-Myers Squibb) has been updated to include data from two clinical trials: a study of Onglyza in patients with moderate to severe renal impairment or end-stage renal disease (ESRD) and a second comparator study of Onglyza + metformin versus glipizide + metformin.
News

Vancomycin Overprescribed in Bloodstream MSSA Infections

In U.S. dialysis centers treating end-stage renal (ESRD) patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia, vancomycin is overprescribed, despite evidence of lower rates of hospitalization and death in cefazolin-treated patients.